share_log

神州细胞(688520.SH):公司在干细胞新产品开发、再生医学方面没有布局

Shenzhou Cell (688520.SH): The company has not laid out in the development of new stem cell products and regenerative medicine.

Gelonghui Finance ·  Nov 15, 2024 01:00

On November 15, Gelonghui reported that Shenzhou Cell (688520.SH) investor relations activity record shows that the company has no layout in stem cell new product development and regenerative medicine.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment